Tanya Hayden - 19 Jun 2022 Form 3 Insider Report for Acer Therapeutics Inc. (ACER)

Role
Chief Operating Officer
Signature
/s/ Harry S. Palmin, Attorney-in-Fact
Issuer symbol
ACER
Transactions as of
19 Jun 2022
Transactions value $
$0
Form type
3
Filing time
22 Jun 2022, 16:04:03 UTC
Next filing
16 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ACER Employee Stock Option (right to buy) 19 Jun 2022 Common Stock 30K $2.96 Direct F1
holding ACER Employee Stock Option (right to buy) 19 Jun 2022 Common Stock 12.5K $2.21 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable over four years as follows: 25% of the shares vest on the one-year anniversary of the grant date, and the remaining 75% of the shares vest quarterly over the remaining three years. The option was granted on June 1, 2021.
F2 The option vests and becomes exercisable over four years as follows: 25% of the shares vest on the one-year anniversary of the grant date, and the remaining 75% of the shares vest quarterly over the remaining three years. The option was granted on January 14, 2022.

Remarks:

Exhibit List: Exhibit 24 - Confirming Statement